23 / 34
Axitinib:
Treatment-related Adverse Events
>25% incidence in any arm
Motzer R, et al. Lancet Oncol 2013
|
|
23 / 34
23 / 34
Axitinib:
Treatment-related Adverse Events
>25% incidence in any arm
Motzer R, et al. Lancet Oncol 2013